Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model
<p>Abstract</p> <p>Background</p> <p>The purpose of this study was to evaluate the biodistribution and toxicity of amphotericin B (AmB) following multiple oral administrations of a novel tropically stable lipid-based formulation (iCo-010).</p> <p>Methods<...
Main Authors: | Owen David, Zhao Jinying, Wasan Ellen K, Lin Molly, Gershkovich Pavel, Sivak Olena, Clement John G, Wasan Kishor M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-08-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://www.lipidworld.com/content/10/1/135 |
Similar Items
-
<it>In vitro </it>cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against <it>Candida albicans</it>, human monocytic and kidney cell lines
by: Clement John G, et al.
Published: (2011-08-01) -
A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model.
by: Ellen K Wasan, et al.
Published: (2010-12-01) -
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
by: Grace Cuddihy, et al.
Published: (2019-02-01) -
Pentoxifylline in prevention of amphotericin B-induced nephrotoxicity and electrolyte abnormalities
by: Mahsa Panahi-Shokouh, et al.
Published: (2020-01-01) -
Intralipid efficacy in decreasing Amphotericin B associated nephrotoxicity
by: Hasibi M, et al.
Published: (2013-03-01)